Back to IPSEYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
2 competitors in Primary Biliary Cholangitis
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Triptorelin pamoate (embonate) saltPhase 3
Advanced Prostate Cancer
Lanreotide (Autogel formulation)Phase 3
Acromegaly
OdevixibatPhase 3
Biliary Atresia
Lanreotide Autogel®Phase 3
Acromegaly
lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose intervalPhase 3
Acromegaly
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts